begin
biostructur
research
provid
tremend
breakthrough
basic
biolog
process
also
significantli
contribut
understand
molecular
mechan
underli
human
diseas
first
exemplifi
max
perutz
colleagu
elucid
molecular
patholog
human
hemoglobin
mutat
lead
sickl
cell
recent
threedimension
structur
mani
human
pathogen
protein
serv
guid
drug
design
increas
number
potenti
target
structur
determin
context
structur
beyond
singleprotein
approach
structur
biolog
en
rout
toward
highresolut
pictur
cell
assess
acid
complex
steadili
increas
level
complex
clear
ever
integr
understand
molecular
mechan
human
diseas
emerg
path
although
major
challeng
lie
translat
knowledg
therapeut
strategi
earli
septemb
structur
biologist
biochemist
met
picturesqu
town
murnau
locat
near
staffelse
lake
bavarian
alpin
upland
reflect
question
discuss
recent
biostructur
data
molecular
determin
human
diseas
includ
microbi
viral
infect
protein
misfold
diseas
cancer
metabol
disord
topic
address
five
scientif
session
two
poster
session
ampl
time
discuss
scientif
part
meet
complement
tradit
bavarianstyl
social
program
meet
start
murnau
lectur
held
wim
hol
univers
washington
seattl
gave
impress
overview
mechan
matur
activ
cholera
toxin
exampl
medic
structur
genom
pathogen
protozoa
msgpp
program
also
demonstr
power
integr
structur
biolog
biophys
screen
approach
quickli
obtain
new
lead
structur
potenti
drug
first
session
infecti
diseas
open
gabriel
waksman
univers
colleg
london
birkbeck
colleg
investig
assembl
process
escherichia
coli
p
pili
structur
crucial
bacteri
virul
combin
structur
biophys
method
waksman
colleagu
shown
donor
strandexchang
mechan
p
pilu
assembl
proce
zip
process
involv
transient
intermedi
complex
key
role
subunit
order
biogenesi
approach
also
led
character
pilicid
smallmolecul
inhibitor
pilu
format
interrupt
interact
chaperon
noncoop
event
cooper
assembl
process
anoth
surfac
structur
involv
virul
gramneg
pathogen
shigella
flexneri
yersinia
pesti
type
iii
secret
system
use
em
xray
crystallographi
molecular
model
steven
johnson
univers
oxford
present
first
nearatom
model
model
protein
associ
needl
structur
basi
regul
assembl
investig
erec
stebbin
rockefel
univers
present
wealth
structur
data
mechan
action
effector
yersinia
protein
kinas
ypka
guanin
nucleotid
dissoci
inhibitor
gdi
gtpase
disrupt
actin
cytoskeleton
host
deshmukh
gopaul
institut
pasteur
present
data
integron
integras
enzym
mediat
recombin
short
symmetr
dna
sequenc
thu
involv
genet
inform
exchang
bacteria
structur
enzym
vibrio
cholera
bound
dna
show
recogn
dna
structur
rather
specif
explor
cellwal
biosynthesi
gunther
kern
gautam
sanyal
astrazeneca
show
glutam
racemas
suitabl
target
narrowspectrum
antimicrobi
agent
sore
need
hospitalacquir
hartmut
niemann
helmholtz
centr
infect
research
univers
bielefeld
show
protein
inlb
listeria
monocytogen
exploit
signal
pathway
receptor
tyrosin
kinas
protooncogen
met
promot
bacteri
uptak
host
cell
find
inlb
function
mimic
natur
ligand
hepatocyt
growth
factorscatt
factor
hgfsf
albeit
bind
met
differ
domain
structur
also
provid
insight
activ
mechan
met
import
cancer
drug
stephen
matthew
imperi
colleg
london
present
latest
result
hostcel
recognit
protozoan
parasit
toxoplasma
gondii
secret
micronem
protein
mic
attach
penetr
host
start
session
viral
diseas
rolf
hilgenfeld
univers
review
work
laboratori
proteas
rna
virus
sever
acut
respiratori
syndrom
sar
coronaviru
coxsackieviru
also
highlight
recent
structur
data
plasmodium
falciparum
discuss
implic
design
activesit
direct
alloster
inhibitor
cystein
young
kwon
peter
kwong
group
us
nation
institut
health
shift
focu
whose
abil
evad
human
immun
system
major
obstacl
vaccin
develop
bind
site
human
receptor
viral
access
antibodi
direct
site
neutral
kwon
compar
structur
complex
nonneutr
antibodi
neutral
antibodi
ref
fig
reveal
upon
bind
hydrophob
surfac
becom
expos
nonneutr
antibodi
bind
denni
bamford
univers
helsinki
explor
architectur
principl
capsid
virus
infect
variou
host
bacteria
human
suggest
earli
cell
infect
mani
differ
virus
limit
number
fold
select
assembl
viabl
viru
elois
mastrangelo
martino
bolognesi
group
univers
milan
present
work
proteasehelicas
kunjin
viru
flaviviru
affect
livestock
man
smallangl
xray
scatter
sax
data
reveal
domain
rearrang
upon
rna
bind
may
explain
unwind
effici
ref
winfri
weissenhorn
european
molecular
biolog
laboratori
grenobl
present
threedimension
structur
rabi
viru
complex
resolut
reveal
virus
compact
protect
variou
pathogen
effici
clear
bloodstream
complement
system
import
part
innat
immun
complement
protein
activ
form
subject
recent
hot
debat
among
protein
crystallograph
commun
bind
pathogen
tag
phagocytosi
via
complement
receptor
crig
christian
wiesmann
genentech
present
structur
complex
reveal
dramat
structur
rearrang
take
place
complement
wiesmann
colleagu
demonstr
crig
inhibit
altern
pathway
convertas
find
implic
develop
therapeut
target
complement
system
involv
variou
human
diseas
session
protein
misfold
start
roland
riek
salk
institut
recent
return
swiss
feder
institut
technolog
eth
zurich
combin
solidst
nmr
em
hydrogendeuterium
exchang
method
riek
identifi
fibrillogen
sequenc
variou
protein
includ
amyloid
peptid
implic
alzheim
studi
mutant
indic
toxic
relat
morpholog
aggreg
form
riek
also
discuss
use
amyloid
fibril
nanotechnolog
deposit
form
slow
releas
bioactiv
peptid
marcu
leibniz
institut
jena
report
threedimension
em
reconstruct
amyloid
fibril
collabor
niko
grigorieff
brandei
univers
resolut
present
em
map
deviat
significantli
previou
model
entir
differ
fibril
cross
section
basi
fibril
classif
result
also
demonstr
fibril
vastli
heterogen
import
consid
biolog
structur
properti
given
amyloid
sampl
luigi
vitagliano
l
istituto
di
biostruttur
e
bioimmagini
consiglio
nazional
dell
ricerch
napl
present
insight
fibril
model
molecular
dynam
calcul
start
crystal
structur
hexa
heptapeptid
eisenberg
laboratori
see
show
minim
stabl
oligom
pentam
hexapeptid
one
peptid
significantli
shield
christian
betzel
univers
hamburg
present
work
aggreg
prion
protein
use
cellfre
assay
convert
cellular
prp
isoform
similar
infecti
form
prpsc
mimick
oxid
stress
sax
analysi
provid
structur
insight
mechan
session
conclud
superb
present
david
eisenberg
univers
california
lo
angel
gave
brief
overview
earli
fibril
model
deriv
imag
move
recent
work
amyloidogen
peptid
basi
crystal
structur
amyloid
peptid
determin
eisenberg
comput
approach
develop
predict
amyloid
propens
peptid
stretch
protein
identifi
lvealyl
human
insulin
potenti
fibrillogen
sequenc
summari
session
gave
good
overview
recent
achiev
field
although
might
long
way
drug
diseas
discov
aloy
alzheim
develop
avail
patient
truli
remark
much
learn
process
year
ago
subject
wild
specul
alan
fersht
univers
cambridg
open
session
cancer
report
tumorsuppressor
protein
inact
half
human
cancer
mani
case
mutat
lower
thermal
stabil
core
domain
bodi
temperatur
fersht
group
design
compound
rescu
function
mutant
potenti
cancer
therapeut
crystal
structur
oncogen
mutant
reveal
caviti
could
appropri
target
drug
design
chemic
rescu
function
final
combin
sax
em
nmr
studi
togeth
previou
crystallograph
data
result
complet
architectur
tetram
includ
larg
intrins
unstructur
holger
rehmann
univers
medic
centr
utrecht
report
structur
basi
regul
guanin
nucleotid
exchang
factor
epac
alfr
wittinghof
maxplanck
institut
dortmund
appli
detail
understand
gtpase
reaction
ra
devis
potenti
strategi
cancer
therapi
wittinghof
group
found
small
molecul
undisclos
structur
could
induc
activ
oncogen
inact
ra
variant
guillermo
montoya
spanish
nation
cancer
center
madrid
report
molecular
basi
substrat
recognit
pololik
kinas
implic
centrosom
clau
kuhn
gene
center
munich
report
function
architectur
yeast
rna
polymeras
carri
synthesi
ribosom
rna
question
unravel
combin
cryoem
xray
crystallographi
homolog
model
biochem
genet
experi
nice
complement
structur
data
show
rna
polymeras
deviat
structur
function
rna
polymeras
final
titia
sixma
netherland
cancer
institut
amsterdam
collabor
andrea
pichler
medic
univers
vienna
frauk
melchior
univers
report
crystal
structur
sumoyl
show
sumoyl
affect
enzymat
activ
modul
interact
recognit
sumoyl
site
depend
surround
structur
site
final
show
sumo
bind
differ
site
depend
whether
coval
thioesterlink
complex
modifi
lysin
noncoval
complex
final
session
start
structur
extracellular
receptor
involv
metabol
control
cardiovascular
diseas
michael
lawrenc
walter
eliza
hall
institut
present
crystal
structur
insulin
receptor
ectodomain
complex
four
fab
insulin
mimet
therebi
provid
first
view
spatial
arrang
low
highaffin
insulin
bind
site
fritz
univers
konstanz
present
unpublish
structur
ligand
bind
domain
rage
multiligand
receptor
advanc
glycat
end
product
protein
whose
activ
key
numer
chronic
diseas
diabet
inflamm
arteriosclerosi
neurodegener
make
potenti
therapeut
armin
ruf
hoffmannla
roch
provid
view
structureguid
design
two
newli
identifi
class
dual
agonist
whose
profil
seem
well
suit
address
hyperglycemia
well
enhanc
cardiovascular
risk
diabet
annalisa
pastor
medic
research
council
london
shift
focu
session
rare
diseas
recent
find
anomal
expans
polyglutamin
motif
basi
neurodegen
misfold
antti
haapalainen
univers
oulu
present
structur
function
studi
human
mitochondri
acetoacteylcoa
thiolas
whose
lossoffunct
mutat
result
sever
marku
wahl
maxplanck
institut
combin
structur
function
studi
search
molecular
basi
retin
pigmentosa
rp
data
support
model
spliceosom
factor
whose
mutat
caus
sever
form
serv
scaffold
assembl
factor
dead
box
protein
gtpase
show
viabl
mutat
weaken
abolish
ryota
kuroki
japan
atom
energi
agenc
present
recent
structur
studi
complex
human
granulocyt
factor
gcsf
cytokin
use
treatment
granulopenia
receptor
although
variou
stochiometri
propos
assembl
kuroki
work
underscor
relev
complex
result
line
thermodynam
mutat
roger
william
medic
research
council
cambridg
close
session
comprehens
overview
recent
structur
result
cellular
escrt
mediat
traffick
monoubiquitin
protein
lysosom
via
multivesicular
bud
mvb
pathway
process
role
downregul
cellsurfac
receptor
bud
hiv
retrovirus
william
discuss
molecular
understand
reach
mani
compon
mvb
pathway
molecular
assembl
sort
signal
ubiquitin
major
challeng
remain
understand
higherlevel
molecular
organ
escrt
lattic
togeth
molecular
mechan
vesicl
bud
solut
challeng
requir
applic
hybrid
method
close
resolut
gap
xray
structur
current
em
reconstruct
summari
murnau
confer
featur
present
poster
mani
molecular
aspect
underli
human
diseas
sever
present
demonstr
advanc
molecular
understand
diseaserelev
factor
open
new
strategi
design
interf
small
molecul
screen
procedur
compound
case
complex
supramolecular
assembl
solv
structur
method
seem
overwhelm
current
abil
translat
emerg
higherord
molecular
view
concret
option
therapeut
intervent
demonstr
hol
waksman
fersht
wittinghof
riek
mani
other
step
come
within
reach
structur
biolog
research
tightli
integr
biophys
biochem
cellular
studi
strategi
integr
function
structur
studi
ever
complex
cellular
process
search
new
therapeut
entri
point
reflect
mani
present
discuss
murnau
upcom
meet
may
interest
focu
interfac
structur
chemic
biolog
structur
inform
use
reveal
action
mechan
new
bioactiv
compound
improv
intervent
